FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994477529> ?p ?o ?g. }

• W1994477529 abstract "Abstract Background Topoisomerase IIα has been shown to be down-regulated in doxorubicin-resistant cell lines. The specificity proteins Sp1 and Sp3 have been implicated in regulation of topoisomerase IIα transcription, although the mechanism by which they regulate expression is not fully understood. Sp1 has been shown to bind specifically to both proximal and distal GC elements of the human topoisomerase IIα promoter in vitro , while Sp3 binds only to the distal GC element unless additional flanking sequences are included. While Sp1 is thought to be an activator of human topoisomerase IIα, the functional significance of Sp3 binding is not known. Therefore, we sought to determine the functional relationship between Sp1 and Sp3 binding to the topoisomerase IIα promoter in vivo . We investigated endogenous levels of Sp1, Sp3 and topoisomerase IIα as well as binding of both Sp1 and Sp3 to the GC boxes of the topoisomerase IIα promoter in breast cancer cell lines in vivo after short term doxorubicin exposure. Results Functional effects of Sp1 and Sp3 were studied using transient cotransfection assays using a topoisomerase IIα promoter reporter construct. The in vivo interactions of Sp1 and Sp3 with the GC elements of the topoisomerase IIα promoter were studied in doxorubicin-treated breast cancer cell lines using chromatin immunoprecipitation assays. Relative amounts of endogenous proteins were measured using immunoblotting. In vivo DNA looping mediated by proteins bound at the GC1 and GC2 elements was studied using the chromatin conformation capture assay. Both Sp1 and Sp3 bound to the GC1 and GC2 regions. Sp1 and Sp3 were transcriptional activators and repressors respectively, with Sp3 repression being dominant over Sp1-mediated activation. The GC1 and GC2 elements are linked in vivo to form a loop, thus bringing distal regulatory elements and their cognate transcription factors into close proximity with the transcription start site. Conclusion These observations provide a mechanistic explanation for the modulation of topoisomerase IIα and concomitant down-regulation that can be mediated by topoisomerase II poisons. Competition between Sp1 and Sp3 for the same cognate DNA would result in activation or repression depending on absolute amounts of each transcription factor in cells treated with doxorubicin." @default.
• W1994477529 created "2016-06-24" @default.
• W1994477529 creator A5005021921 @default.
• W1994477529 creator A5005590357 @default.
• W1994477529 creator A5043903784 @default.
• W1994477529 date "2007-05-20" @default.
• W1994477529 modified "2023-09-26" @default.
• W1994477529 title "Down-regulation of human topoisomerase IIα expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions" @default.
• W1994477529 cites W1483692899 @default.
• W1994477529 cites W1512813342 @default.
• W1994477529 cites W1528082486 @default.
• W1994477529 cites W1547338899 @default.
• W1994477529 cites W1969870278 @default.
• W1994477529 cites W1974004139 @default.
• W1994477529 cites W1986378909 @default.
• W1994477529 cites W1988086962 @default.
• W1994477529 cites W1990189563 @default.
• W1994477529 cites W2004159494 @default.
• W1994477529 cites W2015892679 @default.
• W1994477529 cites W2018289835 @default.
• W1994477529 cites W2025495522 @default.
• W1994477529 cites W2027022789 @default.
• W1994477529 cites W2028350144 @default.
• W1994477529 cites W2029827117 @default.
• W1994477529 cites W2032757127 @default.
• W1994477529 cites W2033907031 @default.
• W1994477529 cites W2040132766 @default.
• W1994477529 cites W2042469661 @default.
• W1994477529 cites W2043435962 @default.
• W1994477529 cites W2044523536 @default.
• W1994477529 cites W2046667138 @default.
• W1994477529 cites W2049104063 @default.
• W1994477529 cites W2051982697 @default.
• W1994477529 cites W2073026107 @default.
• W1994477529 cites W2080053060 @default.
• W1994477529 cites W2083819673 @default.
• W1994477529 cites W2084920003 @default.
• W1994477529 cites W2088622701 @default.
• W1994477529 cites W2089126365 @default.
• W1994477529 cites W2094747148 @default.
• W1994477529 cites W2099997590 @default.
• W1994477529 cites W2100837269 @default.
• W1994477529 cites W2106169455 @default.
• W1994477529 cites W2111301002 @default.
• W1994477529 cites W2116930183 @default.
• W1994477529 cites W2118162624 @default.
• W1994477529 cites W2132068224 @default.
• W1994477529 cites W2132600317 @default.
• W1994477529 cites W2144353720 @default.
• W1994477529 cites W4323053706 @default.
• W1994477529 doi "https://doi.org/10.1186/1471-2199-8-36" @default.
• W1994477529 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1885802" @default.
• W1994477529 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17511886" @default.
• W1994477529 hasPublicationYear "2007" @default.
• W1994477529 type Work @default.
• W1994477529 sameAs 1994477529 @default.
• W1994477529 citedByCount "25" @default.
• W1994477529 countsByYear W19944775292012 @default.
• W1994477529 countsByYear W19944775292014 @default.
• W1994477529 countsByYear W19944775292015 @default.
• W1994477529 countsByYear W19944775292016 @default.
• W1994477529 countsByYear W19944775292017 @default.
• W1994477529 countsByYear W19944775292018 @default.
• W1994477529 countsByYear W19944775292019 @default.
• W1994477529 countsByYear W19944775292022 @default.
• W1994477529 countsByYear W19944775292023 @default.
• W1994477529 crossrefType "journal-article" @default.
• W1994477529 hasAuthorship W1994477529A5005021921 @default.
• W1994477529 hasAuthorship W1994477529A5005590357 @default.
• W1994477529 hasAuthorship W1994477529A5043903784 @default.
• W1994477529 hasBestOaLocation W19944775291 @default.
• W1994477529 hasConcept C101762097 @default.
• W1994477529 hasConcept C104317684 @default.
• W1994477529 hasConcept C134320426 @default.
• W1994477529 hasConcept C138885662 @default.
• W1994477529 hasConcept C147897179 @default.
• W1994477529 hasConcept C150194340 @default.
• W1994477529 hasConcept C153911025 @default.
• W1994477529 hasConcept C179926584 @default.
• W1994477529 hasConcept C207001950 @default.
• W1994477529 hasConcept C41895202 @default.
• W1994477529 hasConcept C54355233 @default.
• W1994477529 hasConcept C552990157 @default.
• W1994477529 hasConcept C55493867 @default.
• W1994477529 hasConcept C57467964 @default.
• W1994477529 hasConcept C83640560 @default.
• W1994477529 hasConcept C86339819 @default.
• W1994477529 hasConcept C86803240 @default.
• W1994477529 hasConcept C88045685 @default.
• W1994477529 hasConceptScore W1994477529C101762097 @default.
• W1994477529 hasConceptScore W1994477529C104317684 @default.
• W1994477529 hasConceptScore W1994477529C134320426 @default.
• W1994477529 hasConceptScore W1994477529C138885662 @default.
• W1994477529 hasConceptScore W1994477529C147897179 @default.
• W1994477529 hasConceptScore W1994477529C150194340 @default.
• W1994477529 hasConceptScore W1994477529C153911025 @default.
• W1994477529 hasConceptScore W1994477529C179926584 @default.
• W1994477529 hasConceptScore W1994477529C207001950 @default.
• W1994477529 hasConceptScore W1994477529C41895202 @default.
• W1994477529 hasConceptScore W1994477529C54355233 @default.

• next